Dr. Sulaiman Al Habib Medical Services Group Company
4013.SRSAUHealthcare● Active
$218.70
+$2.50(+1.16%)
Market Cap$76.5B
P/E Ratio—
52W High$281.2
52W Low$211.5
Dr. Sulaiman Al Habib Medical Services Group Company（4013.SR）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · 4013.SR · 截至 2026-06-15
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $13.71B | $11.20B | $9.51B | $8.31B | $7.25B |
| Cost of Revenue | $9.50B | $7.46B | $6.29B | $5.56B | $4.92B |
| Gross Profit | $4.21B | $3.74B | $3.25B | $2.75B | $2.33B |
| Gross Margin %(computed) | 30.69% | 33.43% | 34.22% | 33.07% | 32.14% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.22B | $0.16B | $0.16B | $0.13B | $0.10B |
| Total Operating Expenses | $1.59B | $1.39B | $1.10B | $1.04B | $0.85B |
| Operating Income | $2.64B | $2.36B | $2.10B | $1.70B | $1.47B |
| Operating Margin %(computed) | 19.26% | 21.04% | 22.04% | 20.46% | 20.22% |
| Interest Income | $0.05B | $0.06B | $0.08B | $0.04B | $0.01B |
| Interest Expense | $0.36B | $0.18B | $0.08B | $0.06B | $0.05B |
| Income Before Tax | $2.52B | $2.41B | $2.17B | $1.80B | $1.50B |
| Income Tax Expense | $0.03B | $0.04B | $0.07B | $0.11B | $0.11B |
| Net Income | $2.40B | $2.32B | $2.05B | $1.65B | $1.38B |
| Net Margin %(computed) | 17.52% | 20.67% | 21.52% | 19.86% | 18.99% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $6.86 | $6.61 | $5.85 | $4.72 | $3.93 |
| Wtd Avg Shares | 0.35B | 0.35B | 0.35B | 0.35B | 0.35B |
| EBITDA | $3.31B | $2.99B | $2.55B | $2.15B | $1.86B |
| EBITDA Margin %(computed) | 24.15% | 26.72% | 26.85% | 25.84% | 25.62% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-15 · SAR · B
深入了解Dr. Sulaiman Al Habib Medical Services Group Company
关于Dr. Sulaiman Al Habib Medical Services Group Company（4013.SR）损益表
Dr. Sulaiman Al Habib Medical Services Group Company（4013.SR）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，4013.SR实现营收$13.71B，毛利润$4.21B（毛利率30.69%），净利润$2.40B（净利率17.52%）。
常见问题
4013.SR · 4 问Dr. Sulaiman Al Habib Medical Services Group Company（4013.SR）2025财年营收为$13.71B，同比up22.4%。
4013.SR revenue4013.SR salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-15